Tapan Chowdhury, the managing director of Square Pharmaceuticals, has completed the purchase of 15 lakh shares of the company, fulfilling his earlier announcement. The transaction was disclosed ...

Samuel S Chowdhury, chairman of Square Pharmaceuticals, yesterday expressed his willingness to purchase 15 lakh shares of the company, valued at over Tk 32 crore at the current market price.

The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development ...

Tapan Chowdhury, managing director of Square Pharmaceuticals, has expressed his intention to purchase 15 lakh shares of the company—the largest drug producer of the country—valued at over Tk ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Former OKC Thunder star Russell Westbrook recently added a pharmaceutical startup to his investments in Oklahoma City.

Although the square-planar geometry is more common for ... of syntheses for high-value products such as polymers and pharmaceuticals. More information: Yutaka Mondori et al, Monodentate σ ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Park Square Financial Group LLC acquired a new position in shares of Alnylam Pharmaceuticals during the 4th quarter worth approximately $28,000. R Squared Ltd bought a new stake in shares of ...

Steward Partners Investment Advisory LLC acquired a new position in Catalyst Pharmaceuticals during the 4th quarter worth approximately $27,000. Park Square Financial Group LLC purchased a new ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...